Affinity and receptor expression limits tested for LRC-TriCEPS
Dualsystems Biotech AG is testing the limits of the LRC-TriCEPSTM (CaptiRec) technology using antibodies with different affinities against the same target and cells expressing the target receptor with different expression levels.
Details of the assesment see here